- $438.66m
- $445.98m
- $99.99m
Brief: NeuroPace Says Rebecca Kuhn Departs As CFO, To Serve In Advisory Role
Brief: Neuropace Inc - Enters Into Credit Agreement With Midcap Funding Iv Trust
U.S. STOCKS ON THE MOVE- AMC,Natgas companies,Hologic
U.S. STOCKS ON THE MOVE-BellRing, Coeur, AMC Entertainment
NeuroPace falls after epilepsy implant fails to meet main study goal
Brief: NeuroPace Announces Preliminary Results from One-Year Data in NAUTILUS Study
Neuropace Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Neuropace, Inc. Q1 Revenue USD 22.524 Million Versus. IBES Estimate USD 21.8 Million
Neuropace Inc expected to post a loss of 24 cents a share - Earnings Preview
Brief: Neuropace Provides Update On Tariff Status
Brief: Neuropace Inc Maintaining 2025 Revenue Guidance
Neuropace Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: NeuroPace Reports Fourth Quarter and Full Year 2024 Financial Results
Neuropace Inc expected to post a loss of 22 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Meta Platforms, Dexcom, Dell
U.S. STOCKS ON THE MOVE- Analog Devices, GameStop, Moderna
Neuropace falls on discounted pricing of public offering
Brief: NeuroPace Prices Public Offering Of 6.5 Million Shares At $10 Each
Brief: Neuropace Announces Proposed Public Offering Of $65 Million Of Common Stock